Biomarkers for alzheimer's disease

C - Chemistry – Metallurgy – 12 – Q

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12Q 1/68 (2006.01)

Patent

CA 2718392

The present invention pertains to the domain of Alzheimer's disease (AD), and provides new genetic markers for this disease, distributed on 17 genes. Some of these markers can also be used for predicting an increased risk of developing an early-onset form of Alzheimer's disease. The invention also pertains to a method for in vitro predicting an increased risk, for an individual, of developing Alzheimer's disease, by SNP genotyping. Kits for performing the method are also part of the invention.

La présente invention concerne le domaine de la maladie d'Alzheimer (AD) et porte sur de nouveaux marqueurs génétiques pour cette maladie, distribués sur 17 gènes. Certains de ces marqueurs peuvent également être utilisés pour prédire un risque accru de développer une forme à début précoce de la maladie d'Alzheimer. L'invention porte également sur un procédé pour la prédiction in vitro d'un risque accru, pour un individu, de développer la maladie d'Alzheimer, par un génotypage de SNP. L'invention porte en outre sur des coffrets pour effectuer le procédé.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Biomarkers for alzheimer's disease does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Biomarkers for alzheimer's disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biomarkers for alzheimer's disease will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1902764

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.